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Bisphenol A, an endocrine disrupting compound that affects human 
homeostasis. Studies on BPA are focusing on the impact of BPA in reproductive 
function and brain development. However, the effect of BPA on gut especially 
gastric cells is not well explored. Gut is directly in contact with ingested BPA; 
therefore, we aimed to determine the effect of BPA exposure on gastric cells 
proliferation at safe recommended concentration. Human gastric cancer cells 
(HGC-27) were treated with BPA at different concentration (low: 10-9M, 10-7M; 
high10-5M, 10-4M) and time point (24 hr, 48 hr, 72 hr). Cell viability assays were 
determined using MTS assay. Cells were further stained with Alexa Fluor-635 (F-
actin) and Fluorescein (Hif-1α) protein for immunocytofluorescence. Data 
were analysed using ANOVA (p<0.05, n≥3). Cells treated with 10-9M BPA 
showed significance increase of cell viability after 48 hr (Mean ±SEM; 
146%±0.03, p=0.01) and 72 hr (113%±0.03, p=0.00) compared to 24 hr treatment 
(77%±0.11, p=0.002). Similarly, cell treated with 10-7M BPA showed a 
significance increase after 48 hr (141%±0.03, p=0.03) and 72 hr (190%±0.03, 
p=0.02) compared to 24 hr cells treated with 10-7M (88%±0.05, p=0.01) and 
untreated (100%±0.07). Lower concentration of BPA increases the 
condensation of F-actin in all HGC-27 cells. Meanwhile, translocation of Hif-1α 
protein were observed in all BPA-exposed cells. Findings of this study revealed 
that BPA induced proliferation and condensation of F-actin structure of gastric 
cancer cells at low concentration.  
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1.0  INTRODUCTION 
 
Various studies have demonstrated the adverse 
effects of Bisphenol A (BPA; 4,4-isopropylidene 
diphenol) to human health as well as to the animals 
and environment [1]. BPA is one of the endocrine 
disrupting compounds which acts via estrogen 
receptors and may lead to changes in hormone 
homeostasis. Therefore, BPA is reported to mimic 
natural endogenous estrogen and affects the 
developmental, reproductive, neurological and 
immune system in human through estrogen binding 
receptors. Anteur et al. (2016) reported that BPA 
affects body weight and reproductive function 
likewise the gestational or lactational period of 
pregnant wistar rat [2]. Furthermore, BPA reported to 
cause dysregulation of endocrine receptor signalling 
and associated with development of diseases such as 
cancer [3]. BPA has been linked with the incidence of 
breast cancer [4], hepatoma cancer [5, 6], prostate 
and testicular cancer [7], [8] cardiovascular disease 
[9], diabetes and metabolic syndrome [10]. A few 
studies showed that exposure to BPA at low doses 
could affect cells responses to certain environment or 
stimuli such as hypoxia [11] and insulin resistance [12]. 
In type-2 diabetes mellitus, BPA reported to disturb 
insulin and glucagon regulation [12]. BPA shown to 
affect F-actin formation in human mammary epithelial 
cells [13]. Actin filaments are important to the cells as 
it generates force for biochemical processes and 
determine the cell shape. Dysregulation in F-actin 
signalling due to exposure to BPA may cause cell 
cycle delay in oocytes during meiosis [14]. A 
significant loss in spindles microtubules mass was 
discovered in BPA exposed cells (10 µm and 30 µm) 
during meiosis-I and resulted in small and loosely 
oriented spindles microtubules in meiosis-II. Spindle 
microtubules consist of actin filaments that permeate 
the microtubules during anaphase. 
In hypoxia, BPA exposure is affecting cells ability to 
adapt to hypoxic environment as BPA decreases 
heart rate and tissue vascularization of zebra fish 
embryos [11]. Hypoxia is a condition of oxygen 
depletion which occurs during cellular metabolisms. 
Hypoxia-inducible factor (HIF)-1α is a transcription 
factor known to activate a target genes and protein 
in cells adaptation to low concentration of oxygen. 
Briefly, HIF-1α in active form will dimerize with HIF-1β 
and binds to hypoxia responsive element (HRE) in the 
promoter or enhancer of the target genes. HIF-1 
activity can either enter apoptosis or survival 
pathways which are depending on cell type, severity 
of hypoxia and duration of hypoxia. 
Globally, BPA is one of the most manufactured 
chemicals components in the plastics industry. BPA is 
ubiquitously found in almost every kinds of plasticware 
including food containers, healthcare equipment, 
dental materials, baby bottles, reusable water bottles, 
papers and cardboards. BPA is also widely used as 
inner coating material of canned foods and 
Abstrak 
 
Bisphenol A adalah salah satu daripada sebatian endokrin yang 
mengganggu dan memberi kesan kepada homeostasis manusia. 
Kebanyakan kajian mengenai BPA memberi tumpuan kepada kesan BPA 
dalam fungsi pembiakan dan perkembangan otak. Walau bagaimanapun, 
kesan BPA pada usus terutamanya sel-sel gastrik tidak diterokai dengan baik. 
Perut secara langsung bersentuhan dengan BPA yang dimakan; oleh itu, kami 
bertujuan untuk menentukan kesan pendedahan BPA terhadap pembiakan 
sel gastrik pada kepekatan yang disarankan selamat. Sel kanser perut 
manusia dirawat dengan BPA pada berbeza kepekatan; (rendah10-9M, 10-7M; 
tinggi10-5M, 10-4M) dan masa (24 jam, 48 jam, 72 jam). Ujian daya maju sel 
ditentukan menggunakan ujian MTS. Sel-sel seterusnya ditandakan dengan 
protein Alexa Fluor-635 (F-actin) dan Fluorescein (Hif-1α) untuk 
immunocytofluorescence. Data dianalisis menggunakan ANOVA (p <0.05, n 
≥3). Sel-sel yang dirawat dengan BPA 10-9M menunjukkan peningkatan daya 
tahan sel selepas 48 jam (Mean ± SEM; 146% ± 0.03, p = 0.01) dan 72 jam (113% 
± 0.03, p = 0.00) berbanding dengan rawatan 24 jam (77%, p=0.002). Begitu 
juga, sel yang dirawat dengan BPA 10-7M menunjukkan peningkatan yang 
signifikan selepas 48 jam (141% ± 0.03, p=0.03) dan 72 jam (190% ± 0.03, p=0.02) 
berbanding dengan sel 24 jam yang dirawat dengan 10-7M (88% 0.05, p=0.01) 
dan tidak dirawat (100% ± 0.07). BPA pada kepekatan yang rendah 
mengganggu kondensasi struktur jaluran F-actin di dalam semua sel. 
Sementara translokasi aktiviti Hif-1α protein dilihat dalam semua sel terdedah 
kepada BPA. Penemuan kajian ini mendedahkan bahawa BPA membantu 
percambahan dan mengganggu struktur F-actin sel kanser gastrik pada 
kepekatan rendah. 
 
Kata kunci: BPA, proliferasi sel, HGC-27, F-actin, Hif-1 alpha  
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beverage which is known as epoxy resins. The 
presence of BPA in canned foods and beverages is to 
prevent rusting in product packaging. Leaching of 
BPA residues into the environment and food product 
have been reported and documented. 
Contamination of BPA in the environment would 
cause a threat to aquatic organisms, wildlife and 
humans as BPA has longer half-lives. The traces of BPA 
have been reported in seafoods sold in a market such 
as prawn, crab, blood cockle, white clam, squid and 
fish at concentration ranging from 13.3 – 213.1 µg/kg 
wet weight. The daily tolerance intake of BPA was set 
from 50 µg BPA per body weight per day to 5 mg BPA 
per body weight per day by United State of America 
Environmental Protection agency (US EPA). Yet various 
studies reported cells exposed to lower doses of the 
BPA had altered morphology, proliferation and 
apoptosis signalling [15]. In Europe, daily uptake of 
BPA for babies was estimated approximately 0.2 
µg/kg through breast feeding and babies of bottle-
fed consumed about 11µg/kg and adults consumed 
about 1.5 µg/kg [12]. 
In human, the most common route of BPA entry is 
through direct ingestion from mouth and it reaches 
the digestive system. The effect of BPA on the gut 
especially gastric cells is not well explored. Study 
shows that low estrogen level able to stimulate 
estrogen receptor alpha 36 and stimulate growth of 
gastric cancer cells [16]. Gastric cancer is the leading 
cause of cancer death worldwide, however 
inadequate understanding of its pathogenesis leads 
to late presentation of this disease [17]. Therefore, this 
study was designed to investigate whether BPA is a 




2.0  METHODOLOGY 
 
All media for cell culture were purchased from Gibco 
LifeTechnologies. Human Gastric Cancer Cell lines 
HGC-27 were purchased from American Type Culture 
Collection (ATCC, USA). Bisphenol A was purchased 
from Sigma Aldrich (USA). HGC-27 was cultured in the 
complete culture medium, respectively in 5% CO2 
incubator at 37°C till 80% confluence. The cells were 
harvested for further tests. 
For cell viability (MTS assay), CellTiter 96® AQueous 
One Solution reagent was used. The 96-well plates 
were transferred to the incubator for 1 hr incubation. 
After 1 hr, the plate was read for absorbance at 490 
nm. Cytotoxicity level is calculated by measuring the 
cell viability as reported by Wang et al. (2011) through 
the conversion of yellow tetrazolium salt to purple 
formazan product. The formazan produces by 
dehydrogenase enzymes were measured by the OD 
values recorded at 490 nm was proportional to the 
number of viable HGC-27 in the culture. Scattered 
graph of BPA concentration against cells viability was 
plotted. Survivability average value was presented in 
percentage (%). Each standard and treatment was 
done in triplicates. The study was repeated for four 
times. 
For immunocytofluorescence staining, HGC-27 
were seeded in 6-well plate containing sterile 
coverslips (0.17 mm thickness) with the density of 300 
000 cells per well with some optimization according to 
manufacturer suggestion (Orange Scientific, Belgium). 
The cells were treated with BPA at different 
concentrations (10-9 M, 10-7 M, 10-5 M, 10-4 M), different 
time-point (F-actin expression for 24 hr, 48 hr, 72 hr; Hif-
1α expression for 72 hr) and untreated cells were used 
as control. Cells were fixed by incubating with 4% 
paraformaldehyde for 15 min and followed by 
permeabilization with 1% triton for 20 min. The cells 
were blocked with 10% BSA for 1 hr. After 1 hr, the cells 
were first incubated with HIF-1α (Abcam, UK; 1:500 
dilutions) for 1 hr then followed by fluorophore-
conjugated secondary antibodies, Fluorescein and 
Alexa-635 phaloidin for F-actin (Invitrogen, USA; 1:1000 
dilutions) for 1 hr. The cells were counterstained with 
DAPI for 5 min. The coverslips were left to dry out and 
mounted after 30 min. The glass slide was viewed 
under fluorescence microscope. Successfully stained 
HGC-27 was verified as the structure of cytoskeleton; 
F-actin (red), Hif-1 alpha (green) and nuclei (blue). The 
experiment was repeated three times. 
 
 
3.0  RESULTS AND DISCUSSION 
 
3.1  The Effects of BPA at Different Concentration on 
HGC-27 Cells Viability 
 
For cell viability study, the HGC-27 cells were treated 
with BPA at concentrations of 10-9 M, 10-7 M, 10-5 M, 
and 10-4 M (Figure 1) for 24 hr, 48 hr and 72 hr.  In 24 hr 
treatment, cells treated with BPA at concentration 10-
9(mean, ± SEM; 77%, ± 0.11, p = 0.002), 10-7 (88% ± 0.05, 
p = 0.01), 10-5 (94% ± 0.03, p = 0.04) and 10-4(53% ± 0.07, 
p = 0.001) showed significance changes compared to 
untreated cells (100% ± 0.07). As for 48 hr, BPA at all 
four concentrations showed significance differences 
at 10-9(146%, ± 0.03, p = 0.00), 10-7 (141% ± 0.03, p = 
0.00), 10-5 (124% ± 0.05, p = 0.01) and 10-4(69% ± 1.02, p 
= 0.01) compared to untreated cells (100% ± 0.03). 
While for 72 hr, significance different was only 
observed at 10-9(113%, ± 0.03, p = 0.00), 10-7 (109% ± 
0.03, p = 0.00) and 10-4(16% ± 0.01, p = 0.00) compared 
to untreated (100% ± 0.02). Cells treated with 10-9 M 
BPA showed a significance increase of cell viability 
after 48 hr (Mean ± SEM; 146% ± 0.03, p = 0.01) and 72 
hr (113% ± 0.03, p = 0.00) compared to 24 hr treatment 
(77% ± 0.11, p = 0.002). Similarly, cell treated with 10-7 
M BPA showed a significance increase after 48 hr 
(141% ± 0.03, p = 0.03) and 72 hr (190% ± 0.03, p = 0.02) 
compared to 24 hr cells treated with 10-7 M (88% ± 0.05, 
p = 0.01) and untreated (100% ± 0.07). In 10-4 BPA 
treatment, a significance reduction of cells viability 
were observed in 24 hr (53% ± 0.07, p = 0.001), 48 hr 
(69% ± 0.102, p = 0.01) and 72 hr (16% ± 0.00, p = 0.01).  
 
 




Figure 1 The effects of BPA at different concentration on 
HGC-27 cells viability. (Indicates statistical significance at p < 
0.05 *; compared to untreated, ** compared to 10-9 M BPA 
exposed for 24 hr; using one-way ANOVA with Bon-ferroni’s 
post hoc test, n = 6 independent observations) 
 
 
Nowadays, gastric cancer cells have been 
reported as one of common malignancies with high 
mortality rate. Continuous research designed to 
investigate the development and progression of the 
gastric cancer cells to combat the disease through 
prevention, diagnosis and treatment. Result obtained 
from this present study revealed that BPA is a potential 
contaminant promoting the gastric cancer cells 
growth (Figure 1) at lower concentration (10-9 M and 
10-7 M) BPA compared to high concentration (10-5 M 
and 10-4 M) BPA. Cells viability of HGC-27 treated with 
24 hr BPA at high doses shown a decrease in cell 
viability. In contrast, cells exposed to 48 hr and 72 hr 
BPA at lower concentration, showed increase in cell 
proliferation. BPA is known as a compound that has 
similar structure to estrogen. Therefore, it is suggested 
that BPA exposure increased the effect of estrogen 
binding and interferes with uterine growth [18]. BPA 
has been reported as weak estrogenic compound 
that trigger weak carcinogenic effect [19]. However, 
in breast cancer cells, BPA reported to increase 
proliferation at lower doses via ERK 1/2 and estrogen 
related receptor gamma (ERRγ) [20]. Interestingly, BPA 
at 10-6 M promote highest proliferation rate in normal 
breast cells, HBL-100 and promotes the expression of 
cyclin D1 and CDK4, implicated in cells progression 
[21]. Moreover, in prostate cancer cells, BPA shown to 
activate androgen receptor and mitogenesis (8). The 
mechanisms of BPA in regulating cells proliferation 
and inhibition are reported to be cell specific and 
depending on the genetic and epigenetic regulation. 
 
3.2  BPA Affects F-actin Expression in HGC-27 
 
In the second part, the HGC-27 cells were stained with 
F-actin to observe the cellular effects of BPA on the 
actin at different concentrations (10-9 M, 10-7 M, 10-5 M, 
and 10-4 M) and time-point (24 hr, 48 hr and 72 hr). At 
24 hr, the striated actin were observed in HGC-27, 
however the expression were decreased in HGC-27 
treated with BPA at 10-5 M (Figure 2 D) and 10-4 M 
(Figure 2 E). The expression of striated actin was 
increased in HGC-27 treated with BPA at 10-9 M (Figure 
2 B) and 10-7 M (Figure 2 C). 
 
 
Figure 2 The HGC-27 treated -BPA stained for F-actin at 24 hr. 
The HGC-27 stained with DAPI for nucleus (blue) and Alexa-
635 phaloidin for F-actin (red) for (A) untreated, (B) 10-9 M, (C) 
10-7 M, (D) 10-5 M, (E) 10-4 M. The changes were viewed under 
fluorescence microscope at 20× magnification as a network 




At 48 hr, the actin expression was more prominent 
in HGC-27 treated with BPA at 10-9 M (Figure 3 B), 10-7 
M (Figure 3 C), 10-5 M (Figure 3 D) and 10-4 M (Figure 3 
E). However, the filaments were observed more 
condensed actin expression in HGC-27 treated with 
BPA at concentration 10-9 M (Figure 3 B), 10-5 M (Figure 
3 D) and 10-4 M (Figure 3 E) compared to untreated 
(Figure 3 A). The HGC-27 treated with BPA at 
concentration 10-7 M (Figure 3 C) was observed to 
have less condensed expression of actin. 
 






























Figure 3 The HGC-27 treated -BPA stained for F-actin at 48 hr. 
The HGC-27 stained with DAPI for nucleus (blue) and Alexa-
635 phaloidin for F-actin (red) for (A) untreated, (B) 10-9 M, (C) 
10-7 M, (D) 10-5 M, (E) 10-4 M. The changes were viewed under 
fluorescence microscope at 20× magnification as a network 




At 72 hr, the actin was more condensed in HGC-27 
treated with BPA at all concentrations as compared 
to the untreated (Figure 4 A). The HGC-27 treated with 
BPA at 10-7 M (Figure 4 C) and 10-5 M (Figure 4 D) 
showed more condensed actin as compared to 
untreated. The HGC-27 treated with BPA at 10-9 M 
(Figure 4 B) show no effect on the actin structures. The 
result shows that the HGC-27 treated with BPA at 
concentration 10-9M were not affecting the actin 
structure. 
Actin is the most abundant protein in eukaryotic 
cells in the form of monomeric (G-protein) and 
filamentous (F-actin) for the maintenance of the cell 
shape [22]. Actin polymerization in cells is very 
important for cellular events such as endocytosis, 
adhesion, cytokinesis and membrane division. 
Nonetheless, BPA shown to interrupt the actin 
filaments elongation [23]. HGC-27 cells were 
polygonal or short spindle-shaped that adhered to 
glass surfaces as monolayer [24]. A spindle-shaped 
structure composed of microtubules and actin 
filaments, which form near the cell nucleus. 
Microtubules are important for the cells during cell 
division and organelle movement. Disruption of 
microtubules by BPA may disrupt mitotic spindle and 
induced metaphase arrest [25]. Disruption of actin 
filaments by BPA is not well understood. 
 
Figure 4 The HGC-27 treated -BPA stained for F-actin at 72 hr. 
The HGC-27 stained with DAPI for nucleus (blue) and Alexa-
635 phaloidin for F-actin (red) for (A) untreated, (B) 10-9 M, (C) 
10-7 M, (D) 10-5 M, (E) 10-4 M. The changes were viewed under 
fluorescence microscope at 20× magnification as a network 




In here, we observed the effects of low 
concentration of BPA on F-actin structures of HGC-27 
cells. F-actin structures of HGC-27 treated with BPA at 
lower doses, 10-9 and 10-7 were more condensed 
(Figure 3) than BPA at high doses, 10-5 and 10-4 (Figure 
3). BPA at high doses does not affect the F-actin 
striated structure and it was similar to untreated HGC-
27 (Figure 4). HGC-27 shows positive actin expression 
in untreated and all treated cells at 24 hr BPA exposure 
(Figure 2). The results suggested that BPA interrupts the 
filamentous actin of HGC-27 and regulates gastric 
cancer cells proliferation. Apart from BPA, 
perfluorooctanesulfonate (PFOS) is another types of 
endocrine disrupting compound which reported in 
affecting the cell-cell interface in maintaining the 
barrier functions of sertoli cell blood-testis [26]. 
Disorganized actin-filament bundles results in 
disorganized branched network thus result in F-actin 
network truncation and defragmentation. PFOS is 
affecting actin regulatory protein, Arp3, a branched 
actin polymerization protein dislocation [27]. 
 
3.3  The HGC-27 Exposed to BPA Regulates Hif-1α 
Protein Expression at 72 hr 
 
As BPA showed more effects on the F-actin after 72 hr 
treatment, the subsequent experiment was done in 72 
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hr treated-BPA only for Hif-1α protein expression. The 
association of Hif-1α proteins expression with the 
condensation of F-actin striated structure were 
observed. Figure 5 shows representative diagram of 
HGC-27 stained with DAPI for nucleus (blue) and 
fluorescein (green) for Hif-1 alpha protein at 72 hr. In 
untreated cells, high expressions of Hif-1 alpha protein 
were observed in the cytoplasm. While, low expression 
of Hif-1 alpha protein in the nucleus was observed in 
10-⁹ M (Figure 5 B) and 10-⁷ M (Figure 5 C) BPA 
compared to untreated. Interestingly, increased of Hif-
1 alpha protein expression in the nucleus were 
observed in 10-⁵ M (Figure 5 D) and 10-⁴ M (Figure 5 E).  
 
Figure 5 The expression of Hif-1 alpha protein in HGC-27 
treated with BPA at 72 hr. The HGC-27 cells from (A) 
untreated, (B) 10-9 M, (C) 10-7 M, (D) 10-5 M and (E) 10-4 M were 
stained. The changes were viewed under fluorescence 
microscope at 20× magnification; a representative of 3 
independent observation (n=3) 
 
 
In solid tumor, hypoxia is known as a major 
disturbance towards an effective cancer therapy. Hif-
1 protein is a major oxygen regulator. It is a 
heterodimeric transcription factor consists of two 
subunits known as Hif-1 alpha and Hif-1 beta. Hif-1 
beta is constitutively expressed because it is oxygen 
dependent nuclear protein. While Hif-1 alpha is rapidly 
degraded in normoxic environment. Inactivation of 
Hif-1 alpha hydroxylation activity stabilizes the Hif-1 
alpha and promotes apoptosis in cells. BPA reported 
to inhibits Hif-1 alpha regulation and interfere with 
mRNA expression, protein synthesis, protein 
degradation and dimerization, DNA binding and 
transcriptional of Hif-1 protein activity [28]. 
Here, our results suggest that BPA might play a role in 
stabilizing the Hif-1 alpha protein expression at high 
and lower concentration (Figure 5). Translocation of 
activated Hif-1 alpha into nucleus was observed in 
BPA exposure on HGC-27 cells. In contrast, previous 
study showed that BPA inhibits hypoxic response via 
degradation of Hif-1 alpha of human hepatoma cells. 
While, our result showed expression of Hif-1 alpha in 
both high and low concentration of BPA-treated 
gastric cancer cells (Figure 5) and a reduction of cell 
viability was observed (Figure 1). Thus, BPA at high 
concentration, 10-5 and 10-4 shown to upregulates Hif-
1 alpha expressions and reduces growth in HGC-27 
cancer cell after 72 hr. Study found that reduction in 
Hif-1 alpha expression regulates gastric cancer 
growth, angiogenesis and vessel maturation. 
However, in gastric cancer patients, an upregulation 
of Hif-1 alpha was reported by Urano et al. (2006) that 
this is due to low expression of p53 and VEGF protein 
expression, thus increases malignant potential [29]. 
 
 
4.0  CONCLUSION 
 
In summary, the data obtained from this study 
suggested that BPA decreases cells viability of HGC-
27 at high concentration, 10-5 and 10-4 and affecting 
the actin structures of the cells. At lower doses 10-9 and 
10-7 concentration, BPA increases cells viability at 48 hr 
and 72 hr exposure in HGC-27 cells compared to 24 hr. 
The data also suggested that BPA upregulates activity 
of Hif-1 alpha protein at 72 hr exposure in all 
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